USA Domestic Delivery,Canada Domestic Delivery,European Domestic Delivery

Estradiol dipropionate (113-38-2)

Rating:
5.00 out of 5 based on 1 customer rating
SKU: 113-38-2. Category:

AASraw is with synthesis and production ability from gram to mass order of Estradiol dipropionate (113-38-2), under CGMP regulation and trackable quality control system.

Product Description

 

Estradiol dipropionate (113-38-2) video

 

 


 

Estradiol dipropionate (113-38-2) Specification:

Chemical Structure: Product Name: Estradiol dipropionate
  Cas No.: 113-38-2
Molecular Formula: C24H32O4
Molecular Weight: 384.5
Synonyms: estradiol dipropionate

113-38-2

Agofollin

Akrofolline

Diovocyclin

Diprostron

Estroici

Storage: Dry, dark
Documents(COA & HPLC etc.): Available

 

Estradiol dipropionate (113-38-2) Description:

Estradiol dipropionate (EDP) powder, sold under the brand names Agofollin, Di-Ovocyclin, and Progynon DP among others, is an estrogen medication which has been used in hormone therapy for menopausal symptoms and low estrogen levels in women and in the treatment of gynecological disorders. It has also been used in feminizing hormone therapy for transgender women and in the treatment of prostate cancer in men.

As the primary, most potent estrogen hormone produced by the ovaries, estradiol binds to and activates specific nuclear receptors. This agent exhibits mild anabolic and metabolic properties, and increases blood coagulability. (NCI04)

 

Reference:

  • 1, Kuhl H (2005). “Pharmacology of estrogens and progestogens: influence of different routes of administration” (PDF). Climacteric. 8 Suppl 1: 3–63. doi:10.1080/13697130500148875. PMID 16112947.
  • 2, Düsterberg B, Nishino Y (December 1982). “Pharmacokinetic and pharmacological features of oestradiol valerate”. Maturitas. 4 (4): 315–24. doi:10.1016/0378-5122(82)90064-0. PMID 7169965.
  • 3, Stanczyk, Frank Z.; Archer, David F.; Bhavnani, Bhagu R. (2013). “Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment”. Contraception. 87 (6): 706–727.
  • 4, Nestorović N, Trifunović S, Manojlović-Stojanoski M, Jarić I, Ristić N, Filipović B, Šošić-Jurjević B, Milošević V. Soy Phytoestrogens Do Not Fully Reverse Changes in Rat Pituitary Castration Cells: Unbiased Stereological Study. Anat Rec (Hoboken). 2018 Mar 23. doi: 10.1002/ar.23809. [Epub ahead of print] PubMed PMID: 29569839.
  • 5, Ristic N, Ajdzanovic V, Manojlovic-Stojanoski M, Maliković J, Uscebrka G, Markovic Z, Milosevic V. Effects of Estradiol on Histological Parameters and Secretory Ability of Pituitary Mammotrophs in Ovariectomized Female Rats. Cell J. 2017 Oct;19(3):461-468. doi: 10.22074/cellj.2017.4334. Epub 2017 Aug 19. PubMed PMID: 28836408; PubMed Central PMCID: PMC5570411.ate. C25H34O3 = 382.5. CAS — 15140-27-9.

 

PRECAUTION AND DISCLAIMER:

This Material is Sold For Research Use Only. Terms of Sale Apply. Not for Human Consumption, nor Medical, Veterinary, or Household Uses.